The global dry eye disease market is experiencing strong growth owing to the rising incidence of dry eye disease across the globe and increase in demand for safe and effective treatment. Moreover, rise in focus on the development of dry eye disease treatments and growing geriatric population is expected to boost the market growth. However, factors such as availability of alternative therapeutics/therapies and high cost of dry eye products are expected to hamper growth of the market.
Global Dry Eye Disease Market Drivers:
Rising incidence of dry eye disease across the globe is expected to boost the growth of the global dry eye disease market during the forecast period. For instance, dry eye disease is a multifactorial disease of the ocular surface with loss of homeostasis of the tear film & ocular symptoms. As per the National Institutes of Health (NIH), studies have estimated that over 344 million people around the world and 16.4 million adults in the U.S. have some form of dry eye disease. It is believed that around 70% of DED cases are owing to some form of evaporative dry eye, for which Meibomian gland dysfunction (MGD) is the major cause.
0
